Document Detail


Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine.
MedLine Citation:
PMID:  9459277     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The zona pellucida (ZP) surrounding a mammalian oocyte mediates the initial recognition and binding of spermatozoon to oocyte in a relatively species-specific manner and plays an important role in the subsequent activation events during the fertilization process. The ZP comprises three biochemically and immunologically distinct glycoproteins termed ZP1, ZP2 and ZP3. The critical role of ZP glycoproteins in reproduction together with their tissue-specific nature have led to their being considered as potential candidate antigens for immunocontraception. Immunization of females with ZP glycoproteins leads to a block of fertility in several animal models. However, it is invariably associated with either a transient or an irreversible alteration in the cyclicity, hormonal profile and follicular development in the ovary. To overcome these problems, attempts are being made to delineate relevant 'B' cell epitopes on ZP proteins so as to design immunocontraceptive vaccines based on synthetic peptides devoid of oophoritogenic 'T' cell epitopes. Monoclonal antibodies capable of inhibiting the gamete interaction are being employed to delineate such regions. Additionally, DNA-recombinant technology has made it feasible to obtain, in reasonably large quantities, the ZP glycoproteins from human and non-human primates. Availability of sequence information of these zona proteins and the availability of recombinant antigens (devoid of other ovarian-associated proteins) will further help in understanding more precisely their functions during fertilization and make it feasible to undertake immunization studies to determine their prospects as immunogens for fertility regulation.
Authors:
S K Gupta; P Jethanandani; A Afzalpurkar; R Kaul; R Santhanam
Related Documents :
12385837 - Transforming growth factor beta--a mediator of immune deviation in seminal plasma.
1607367 - Autolytic transition of mu-calpain upon activation as resolved by antibodies distinguis...
2451647 - Monoclonal antibody labelling of human spermatozoa: an electron microscope study.
6749557 - Impairment of rat spermatogenesis following unilateral experimental ischemia.
93547 - Ontogeny of immunity in amphibians: changes in antibody repertoires and appearance of a...
6319057 - Epstein-barr virus induced pneumococcal antibody production in man. a comparison of dif...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Human reproduction update     Volume:  3     ISSN:  1355-4786     ISO Abbreviation:  Hum. Reprod. Update     Publication Date:    1997 Jul-Aug
Date Detail:
Created Date:  1998-03-04     Completed Date:  1998-03-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9507614     Medline TA:  Hum Reprod Update     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  311-24     Citation Subset:  IM    
Affiliation:
Gamete Antigen Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India. GA@nii.ernet.in
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Antigens / chemistry,  immunology
Contraception, Immunologic / methods*
Egg Proteins / chemistry,  immunology*
Female
Humans
Macaca radiata
Male
Membrane Glycoproteins / chemistry,  immunology*
Molecular Sequence Data
Receptors, Cell Surface*
Sperm-Ovum Interactions
Spermatozoa / chemistry,  immunology
Vaccines*
Zona Pellucida / chemistry,  immunology
Chemical
Reg. No./Substance:
0/Antigens; 0/Egg Proteins; 0/Membrane Glycoproteins; 0/Receptors, Cell Surface; 0/Vaccines; 0/zona pellucida glycoproteins
Comments/Corrections
Comment In:
Hum Reprod Update. 1997 Jul-Aug;3(4):299-300   [PMID:  9459275 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fertility regulating and immunotherapeutic vaccines reaching human trials stage.
Next Document:  Prospects of riboflavin carrier protein (RCP) as an antifertility vaccine in male and female mammals...